Integrated Oncology offers a comprehensive menu of diagnostic, prognostic and predictive tests, both routine and complex. We continue to move forward and look for new advances to offer you more.
Here are some of our new and featured tests. Please click the test for additional information
A complete testing portfolio powered by precision medicine
NGS assay evaluating 50 genes associated with myeloid malignancies
for NSCLC, Gastric/GEJ, Cervical Cancer, Melanoma, SCCHN, and Urothelial Carcinoma
therascreen® PIK3CA Mutation Analysis
FDA approved companion diagnostic for advanced breast cancer